Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
Sarasota Arthritis Research Center
mi
from
Sarasota, FL
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
Sarasota Arthritis Research Center
mi
from
Sarasota, FL
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
Ochsner Medical Center
mi
from
New Orleans, LA
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
Ochsner Medical Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
The Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
The Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
University of Michigan-Scleroderma Program
mi
from
Ann Arbor, MI
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
University of Michigan-Scleroderma Program
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
Michigan State University
mi
from
East Lansing, MI
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
Michigan State University
mi
from
East Lansing, MI
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
University of Medicine & Dentistry of New Jersey, UMDNJ Scleroderma Program
mi
from
New Brunswick, NJ
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
University of Medicine & Dentistry of New Jersey, UMDNJ Scleroderma Program
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
Center for Rheumatology
mi
from
Albany, NY
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
Center for Rheumatology
mi
from
Albany, NY
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
Shanahan Rheumatology and Immunotherapy, PLLC
mi
from
Raleigh, NC
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
Shanahan Rheumatology and Immunotherapy, PLLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
Altoona Center for Clinical Research
mi
from
, PA
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
Altoona Center for Clinical Research
mi
from
, PA
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
University of Pittsburgh Department of Rheumatology
mi
from
Pittsburgh, PA
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
University of Pittsburgh Department of Rheumatology
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  9/27/2012
Medical University of South Carolina
mi
from
Charleston, SC
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Propective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 9/27/2012
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Rubber Band Ligation and Mucosectomy for Gastroesophageal Reflux Disease (GERD)
Evaluation of Distal Esophageal and Cardia Rubber Band Ligation and Mucosectomy in the Treatment of Subjects With Gastroesophageal Reflux Disease
Status: Enrolling
Updated:  9/28/2012
Indiana University Hospital
mi
from
Indianapolis, IN
Rubber Band Ligation and Mucosectomy for Gastroesophageal Reflux Disease (GERD)
Evaluation of Distal Esophageal and Cardia Rubber Band Ligation and Mucosectomy in the Treatment of Subjects With Gastroesophageal Reflux Disease
Status: Enrolling
Updated: 9/28/2012
Indiana University Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
The Effects of Vitamin D on Glycemic Control and Proinflammatory Markers in Adolescents With T1DM
The Effects of Vitamin D Supplementation on Glycemic Control and Proinflammatory Markers Involved in Microvascular Complications in Adolescents With Type 1 Diabetes.
Status: Enrolling
Updated:  10/1/2012
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
The Effects of Vitamin D on Glycemic Control and Proinflammatory Markers in Adolescents With T1DM
The Effects of Vitamin D Supplementation on Glycemic Control and Proinflammatory Markers Involved in Microvascular Complications in Adolescents With Type 1 Diabetes.
Status: Enrolling
Updated: 10/1/2012
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Natural Orifice Transgastric Endoscopic Surgical Removal of the Gallbladder
Clinical Outcomes Trial of Laparoscopic Assisted Transgastric Endoscopic Cholecystectomy
Status: Enrolling
Updated:  10/3/2012
Legacy Health System
mi
from
Portland, OR
Natural Orifice Transgastric Endoscopic Surgical Removal of the Gallbladder
Clinical Outcomes Trial of Laparoscopic Assisted Transgastric Endoscopic Cholecystectomy
Status: Enrolling
Updated: 10/3/2012
Legacy Health System
mi
from
Portland, OR
Click here to add this to my saved trials
Rituximab in IgG4-related Disease: A Phase 1-2 Trial
Rituximab in IgG4-Related Disease: A Phase 1-2 Trial
Status: Enrolling
Updated:  10/9/2012
Massachusetts General Hospital
mi
from
Boston, MA
Rituximab in IgG4-related Disease: A Phase 1-2 Trial
Rituximab in IgG4-Related Disease: A Phase 1-2 Trial
Status: Enrolling
Updated: 10/9/2012
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Rituximab in IgG4-related Disease: A Phase 1-2 Trial
Rituximab in IgG4-Related Disease: A Phase 1-2 Trial
Status: Enrolling
Updated:  10/9/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Rituximab in IgG4-related Disease: A Phase 1-2 Trial
Rituximab in IgG4-Related Disease: A Phase 1-2 Trial
Status: Enrolling
Updated: 10/9/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Confocal Endomicroscopy for GI Neoplasia Study
Confocal Endomicroscopy for GI Neoplasia Study
Status: Enrolling
Updated:  10/11/2012
Mayo Clinic Florida
mi
from
Jacksonville, FL
Confocal Endomicroscopy for GI Neoplasia Study
Confocal Endomicroscopy for GI Neoplasia Study
Status: Enrolling
Updated: 10/11/2012
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Proton Pump Inhibitor Therapy and Bone Density in Premature Infants
Proton Pump Inhibitor Therapy and Bone Density in Premature Infants
Status: Enrolling
Updated:  10/17/2012
University of Utah Health Sciences Center
mi
from
Salt Lake City, UT
Proton Pump Inhibitor Therapy and Bone Density in Premature Infants
Proton Pump Inhibitor Therapy and Bone Density in Premature Infants
Status: Enrolling
Updated: 10/17/2012
University of Utah Health Sciences Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
POCone-UBiT-IR300 Pediatric Comparison Study
A Prospective, Multi-Center, Open-Label Study to Compare the POCone® With the Ubit®-IR300 in Measurement of 13CO2/12CO2 Ratio in Breath Samples Collected From Pediatric Subjects Ages 3 to 17 Years With Upper Gastrointestinal Signs and Symptoms
Status: Enrolling
Updated:  10/17/2012
Miami Pediatric Gastroenterology
mi
from
Miami, FL
POCone-UBiT-IR300 Pediatric Comparison Study
A Prospective, Multi-Center, Open-Label Study to Compare the POCone® With the Ubit®-IR300 in Measurement of 13CO2/12CO2 Ratio in Breath Samples Collected From Pediatric Subjects Ages 3 to 17 Years With Upper Gastrointestinal Signs and Symptoms
Status: Enrolling
Updated: 10/17/2012
Miami Pediatric Gastroenterology
mi
from
Miami, FL
Click here to add this to my saved trials
POCone-UBiT-IR300 Pediatric Comparison Study
A Prospective, Multi-Center, Open-Label Study to Compare the POCone® With the Ubit®-IR300 in Measurement of 13CO2/12CO2 Ratio in Breath Samples Collected From Pediatric Subjects Ages 3 to 17 Years With Upper Gastrointestinal Signs and Symptoms
Status: Enrolling
Updated:  10/17/2012
University of Texas School of Public Health
mi
from
El Paso, TX
POCone-UBiT-IR300 Pediatric Comparison Study
A Prospective, Multi-Center, Open-Label Study to Compare the POCone® With the Ubit®-IR300 in Measurement of 13CO2/12CO2 Ratio in Breath Samples Collected From Pediatric Subjects Ages 3 to 17 Years With Upper Gastrointestinal Signs and Symptoms
Status: Enrolling
Updated: 10/17/2012
University of Texas School of Public Health
mi
from
El Paso, TX
Click here to add this to my saved trials
POCone-UBiT-IR300 Pediatric Comparison Study
A Prospective, Multi-Center, Open-Label Study to Compare the POCone® With the Ubit®-IR300 in Measurement of 13CO2/12CO2 Ratio in Breath Samples Collected From Pediatric Subjects Ages 3 to 17 Years With Upper Gastrointestinal Signs and Symptoms
Status: Enrolling
Updated:  10/17/2012
Baylor College of Medicine
mi
from
Houston, TX
POCone-UBiT-IR300 Pediatric Comparison Study
A Prospective, Multi-Center, Open-Label Study to Compare the POCone® With the Ubit®-IR300 in Measurement of 13CO2/12CO2 Ratio in Breath Samples Collected From Pediatric Subjects Ages 3 to 17 Years With Upper Gastrointestinal Signs and Symptoms
Status: Enrolling
Updated: 10/17/2012
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis
Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis
Status: Enrolling
Updated:  10/23/2012
University of Florida
mi
from
Gainesville, FL
Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis
Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis
Status: Enrolling
Updated: 10/23/2012
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Needs Assessment Evaluating Quality of Life Issues for Gastroparesis Patients and Caregivers
Needs Assessment Evaluating Quality of Life Issues for Gastroparesis Patients and Caregivers
Status: Enrolling
Updated:  10/23/2012
University of Florida
mi
from
Gainesville, FL
Needs Assessment Evaluating Quality of Life Issues for Gastroparesis Patients and Caregivers
Needs Assessment Evaluating Quality of Life Issues for Gastroparesis Patients and Caregivers
Status: Enrolling
Updated: 10/23/2012
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Impact of an Antibiotic (Rifaximin) on Liver Scarring in HIV-Infected Patients With Liver Disease
Impact of Rifaximin on Liver Fibrosis in HIV-Infected Patients With Liver Disease
Status: Enrolling
Updated:  10/24/2012
Mount Sinai School of Medicine
mi
from
New York, NY
Impact of an Antibiotic (Rifaximin) on Liver Scarring in HIV-Infected Patients With Liver Disease
Impact of Rifaximin on Liver Fibrosis in HIV-Infected Patients With Liver Disease
Status: Enrolling
Updated: 10/24/2012
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Evaluate the Impact of Drawtex in Venous Leg Ulcers
Clinical Study to Comparatively Evaluate the Impact of Drawtex Wound Dressing Against Wound Bioburden in Moderately to Highly Exuding Venous Leg Ulcers
Status: Enrolling
Updated:  10/29/2012
Southwest Regional Wound Care Center
mi
from
Lubbock, TX
Evaluate the Impact of Drawtex in Venous Leg Ulcers
Clinical Study to Comparatively Evaluate the Impact of Drawtex Wound Dressing Against Wound Bioburden in Moderately to Highly Exuding Venous Leg Ulcers
Status: Enrolling
Updated: 10/29/2012
Southwest Regional Wound Care Center
mi
from
Lubbock, TX
Click here to add this to my saved trials
Optimizing Cimzia in Crohn's Patients
Optimizing Response in Crohn's Disease Patients Who Have Insufficient Initial Response or Who Have Loss of Successful Response to Certolizumab Pegol (Cimzia) Induction Therapy
Status: Enrolling
Updated:  11/1/2012
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
Optimizing Cimzia in Crohn's Patients
Optimizing Response in Crohn's Disease Patients Who Have Insufficient Initial Response or Who Have Loss of Successful Response to Certolizumab Pegol (Cimzia) Induction Therapy
Status: Enrolling
Updated: 11/1/2012
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
A Randomised, Double-blind, Parallel-group, Placebo Controlled Induction Trial to Assess the Clinical Efficacy and Safety of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  11/1/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Chicago, IL
Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
A Randomised, Double-blind, Parallel-group, Placebo Controlled Induction Trial to Assess the Clinical Efficacy and Safety of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 11/1/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
A Randomised, Double-blind, Parallel-group, Placebo Controlled Induction Trial to Assess the Clinical Efficacy and Safety of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  11/1/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Erlanger, KY
Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
A Randomised, Double-blind, Parallel-group, Placebo Controlled Induction Trial to Assess the Clinical Efficacy and Safety of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 11/1/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Erlanger, KY
Click here to add this to my saved trials
Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
A Randomised, Double-blind, Parallel-group, Placebo Controlled Induction Trial to Assess the Clinical Efficacy and Safety of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  11/1/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Hyattsville, MD
Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
A Randomised, Double-blind, Parallel-group, Placebo Controlled Induction Trial to Assess the Clinical Efficacy and Safety of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 11/1/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Hyattsville, MD
Click here to add this to my saved trials
Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
A Randomised, Double-blind, Parallel-group, Placebo Controlled Induction Trial to Assess the Clinical Efficacy and Safety of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  11/1/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Detroit, MI
Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
A Randomised, Double-blind, Parallel-group, Placebo Controlled Induction Trial to Assess the Clinical Efficacy and Safety of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 11/1/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Detroit, MI
Click here to add this to my saved trials
Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
A Randomised, Double-blind, Parallel-group, Placebo Controlled Induction Trial to Assess the Clinical Efficacy and Safety of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  11/1/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Morehead City, NC
Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
A Randomised, Double-blind, Parallel-group, Placebo Controlled Induction Trial to Assess the Clinical Efficacy and Safety of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 11/1/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Morehead City, NC
Click here to add this to my saved trials
Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
A Randomised, Double-blind, Parallel-group, Placebo Controlled Induction Trial to Assess the Clinical Efficacy and Safety of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  11/1/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Memphis, TN
Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
A Randomised, Double-blind, Parallel-group, Placebo Controlled Induction Trial to Assess the Clinical Efficacy and Safety of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 11/1/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
A Randomised, Double-blind, Parallel-group, Placebo Controlled Induction Trial to Assess the Clinical Efficacy and Safety of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  11/1/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Arlington, VA
Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
A Randomised, Double-blind, Parallel-group, Placebo Controlled Induction Trial to Assess the Clinical Efficacy and Safety of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 11/1/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Arlington, VA
Click here to add this to my saved trials
Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
A Randomised, Double-blind, Parallel-group, Placebo Controlled Induction Trial to Assess the Clinical Efficacy and Safety of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  11/1/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Milwaukee, WI
Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
A Randomised, Double-blind, Parallel-group, Placebo Controlled Induction Trial to Assess the Clinical Efficacy and Safety of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 11/1/2012
Novo Nordisk Clinical Trial Call Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Comparison Study of Hemorrhoid Surgery Using the Enseal Device to Standard Hemorrhoid Surgical Techniques
Hemorrhoidectomy Using the Enseal Device: A Comparison to Open Hemorrhoidectomy Techniques
Status: Enrolling
Updated:  11/1/2012
Swedish Medical Center Colon Rectal Clinic
mi
from
Seattle, WA
Comparison Study of Hemorrhoid Surgery Using the Enseal Device to Standard Hemorrhoid Surgical Techniques
Hemorrhoidectomy Using the Enseal Device: A Comparison to Open Hemorrhoidectomy Techniques
Status: Enrolling
Updated: 11/1/2012
Swedish Medical Center Colon Rectal Clinic
mi
from
Seattle, WA
Click here to add this to my saved trials
Polyp Detection With The Peerscope System™
Polyp Detection With The Peerscope System™: A Randomized Tandem Colonoscopy Study
Status: Enrolling
Updated:  11/4/2012
North Shore Gasstroenterology Assoiates, P.C.
mi
from
NY, NY
Polyp Detection With The Peerscope System™
Polyp Detection With The Peerscope System™: A Randomized Tandem Colonoscopy Study
Status: Enrolling
Updated: 11/4/2012
North Shore Gasstroenterology Assoiates, P.C.
mi
from
NY, NY
Click here to add this to my saved trials
Polyp Detection With The Peerscope System™
Polyp Detection With The Peerscope System™: A Randomized Tandem Colonoscopy Study
Status: Enrolling
Updated:  11/4/2012
Southshore Gasstroenterology, P.C
mi
from
NY, NY
Polyp Detection With The Peerscope System™
Polyp Detection With The Peerscope System™: A Randomized Tandem Colonoscopy Study
Status: Enrolling
Updated: 11/4/2012
Southshore Gasstroenterology, P.C
mi
from
NY, NY
Click here to add this to my saved trials
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated:  11/7/2012
Mayo Clinic
mi
from
Phoenix, AZ
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated: 11/7/2012
Mayo Clinic
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated:  11/7/2012
Mayo Clinic - Jacksonville
mi
from
Jacksonville, FL
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated: 11/7/2012
Mayo Clinic - Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated:  11/7/2012
Northwestern University Chicago
mi
from
Chicago, IL
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated: 11/7/2012
Northwestern University Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated:  11/7/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated: 11/7/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated:  11/7/2012
Saint Louis University School of Medicine
mi
from
Saint Louis, MO
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated: 11/7/2012
Saint Louis University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated:  11/7/2012
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated: 11/7/2012
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated:  11/7/2012
Baylor College of Medicine
mi
from
Houston, TX
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated: 11/7/2012
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Single-incision Laparoscopic (SILS) Versus Conventional Laparoscopic Appendectomy for the Treatment of Acute Appendicitis
A Randomized, Controlled Trial of Single-incision Laparoscopic (SILS) Versus Conventional Laparoscopic Appendectomy for the Treatment of Acute Appendicitis
Status: Enrolling
Updated:  11/7/2012
University of California, San Francisco
mi
from
San Francisco, CA
Single-incision Laparoscopic (SILS) Versus Conventional Laparoscopic Appendectomy for the Treatment of Acute Appendicitis
A Randomized, Controlled Trial of Single-incision Laparoscopic (SILS) Versus Conventional Laparoscopic Appendectomy for the Treatment of Acute Appendicitis
Status: Enrolling
Updated: 11/7/2012
University of California, San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Single-incision Laparoscopic (SILS) Versus Conventional Laparoscopic Appendectomy for the Treatment of Acute Appendicitis
A Randomized, Controlled Trial of Single-incision Laparoscopic (SILS) Versus Conventional Laparoscopic Appendectomy for the Treatment of Acute Appendicitis
Status: Enrolling
Updated:  11/7/2012
UCSF Medical Center
mi
from
San Francisco, CA
Single-incision Laparoscopic (SILS) Versus Conventional Laparoscopic Appendectomy for the Treatment of Acute Appendicitis
A Randomized, Controlled Trial of Single-incision Laparoscopic (SILS) Versus Conventional Laparoscopic Appendectomy for the Treatment of Acute Appendicitis
Status: Enrolling
Updated: 11/7/2012
UCSF Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Status: Enrolling
Updated:  11/7/2012
Palms of Pasadena Hospital
mi
from
St. Petersburg, FL
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Status: Enrolling
Updated: 11/7/2012
Palms of Pasadena Hospital
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Status: Enrolling
Updated:  11/7/2012
Bayfront Wound Care & Hyperbaric
mi
from
St. Petersburg, FL
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Status: Enrolling
Updated: 11/7/2012
Bayfront Wound Care & Hyperbaric
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Status: Enrolling
Updated:  11/7/2012
St. Joseph's Baycare Wound Care & Hyperbaric
mi
from
Tampa, FL
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Status: Enrolling
Updated: 11/7/2012
St. Joseph's Baycare Wound Care & Hyperbaric
mi
from
Tampa, FL
Click here to add this to my saved trials